darunavir has been researched along with sildenafil citrate in 1 studies
| Studies (darunavir) | Trials (darunavir) | Recent Studies (post-2010) (darunavir) | Studies (sildenafil citrate) | Trials (sildenafil citrate) | Recent Studies (post-2010) (sildenafil citrate) |
|---|---|---|---|---|---|
| 1,148 | 224 | 780 | 5,862 | 956 | 2,319 |
| Protein | Taxonomy | darunavir (IC50) | sildenafil citrate (IC50) |
|---|---|---|---|
| cGMP-specific 3',5'-cyclic phosphodiesterase | Homo sapiens (human) | 0.0036 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| De Marez, T; De Paepe, E; De Pauw, M; Hoetelmans, RM; Lefebvre, E; Sekar, V; Vangeneugden, T | 1 |
1 trial(s) available for darunavir and sildenafil citrate
| Article | Year |
|---|---|
Effect of repeated doses of darunavir plus low-dose ritonavir on the pharmacokinetics of sildenafil in healthy male subjects: phase I randomized, open-label, two-way crossover study.
Topics: Adolescent; Adult; Anti-HIV Agents; Area Under Curve; Cross-Over Studies; Darunavir; Drug Administration Schedule; Drug Interactions; HIV Protease Inhibitors; Humans; Male; Middle Aged; Phosphodiesterase Inhibitors; Piperazines; Purines; Ritonavir; Sildenafil Citrate; Sulfonamides; Sulfones | 2008 |